| Primary |
| Asthma |
25.0% |
| Diabetes Mellitus |
16.1% |
| Chronic Obstructive Pulmonary Disease |
10.7% |
| Hypertension |
10.7% |
| Coronary Artery Disease |
5.4% |
| Dyspnoea |
5.4% |
| Gastrooesophageal Reflux Disease |
5.4% |
| Hypercholesterolaemia |
5.4% |
| Oedema Peripheral |
5.4% |
| Prophylaxis |
5.4% |
| Cough |
1.8% |
| Lung Adenocarcinoma Stage Iv |
1.8% |
| Respiratory Failure |
1.8% |
|
| Dyspnoea |
15.8% |
| Swollen Tongue |
15.8% |
| Condition Aggravated |
10.5% |
| Product Substitution Issue |
10.5% |
| Bronchospasm |
5.3% |
| Chest Discomfort |
5.3% |
| Cyanosis |
5.3% |
| Lactic Acidosis |
5.3% |
| Loss Of Consciousness |
5.3% |
| Mass |
5.3% |
| Metabolic Acidosis |
5.3% |
| Respiratory Failure |
5.3% |
| Tachycardia |
5.3% |
|
| Secondary |
| Product Used For Unknown Indication |
56.4% |
| Dyspnoea |
6.0% |
| Asthma |
5.5% |
| Chronic Obstructive Pulmonary Disease |
4.1% |
| Diabetes Mellitus |
4.1% |
| Gastric Disorder |
2.8% |
| Hypertension |
2.8% |
| Nausea |
1.8% |
| Restless Legs Syndrome |
1.8% |
| Thyroid Disorder |
1.8% |
| Arthritis |
1.4% |
| Coronary Artery Disease |
1.4% |
| Ex-tobacco User |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Hypercholesterolaemia |
1.4% |
| Nervous System Disorder |
1.4% |
| Oedema Peripheral |
1.4% |
| Prophylaxis |
1.4% |
| Thyroidectomy |
1.4% |
| Apathy |
0.5% |
|
| Poisoning |
13.3% |
| Death |
10.0% |
| Swollen Tongue |
10.0% |
| Toxicity To Various Agents |
10.0% |
| Fall |
6.7% |
| Aphasia |
3.3% |
| Balance Disorder |
3.3% |
| Chronic Obstructive Pulmonary Disease |
3.3% |
| Depression |
3.3% |
| Drug Interaction |
3.3% |
| Dyspnoea |
3.3% |
| Ear Discomfort |
3.3% |
| Gait Disturbance |
3.3% |
| Lactic Acidosis |
3.3% |
| Mass |
3.3% |
| Mesothelioma |
3.3% |
| Musculoskeletal Stiffness |
3.3% |
| Nausea |
3.3% |
| Renal Failure Acute |
3.3% |
| Respiratory Failure |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
48.2% |
| Drug Use For Unknown Indication |
24.0% |
| Asthma |
4.3% |
| Pain |
2.7% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Hypertension |
2.2% |
| Osteoporosis |
2.2% |
| Prophylaxis |
1.9% |
| Thrombosis Prophylaxis |
1.7% |
| Multiple Myeloma |
1.5% |
| Nausea |
1.2% |
| Insomnia |
1.0% |
| Behcet's Syndrome |
1.0% |
| Depression |
1.0% |
| Non-small Cell Lung Cancer |
1.0% |
| Cough |
0.9% |
| Atrial Fibrillation |
0.8% |
| Gastrooesophageal Reflux Disease |
0.7% |
| Anxiety |
0.7% |
| Dyspnoea |
0.7% |
|
| Vomiting |
20.4% |
| Wheezing |
11.6% |
| Pneumonia |
8.8% |
| Sepsis |
6.1% |
| Weight Increased |
6.1% |
| Death |
4.1% |
| Pulmonary Embolism |
4.1% |
| Rash |
4.1% |
| Syncope |
4.1% |
| Pyrexia |
3.4% |
| Dizziness |
2.7% |
| Dyspnoea |
2.7% |
| Fatigue |
2.7% |
| Muscle Spasms |
2.7% |
| Pancreatitis Acute |
2.7% |
| Pneumonitis |
2.7% |
| Respiratory Failure |
2.7% |
| Tooth Disorder |
2.7% |
| Urinary Tract Infection |
2.7% |
| Weight Decreased |
2.7% |
|
| Interacting |
| Dyspnoea |
36.4% |
| Gastric Disorder |
18.2% |
| Arthritis |
9.1% |
| Nervous System Disorder |
9.1% |
| Sarcoma |
9.1% |
| Smoking Cessation Therapy |
9.1% |
| Thyroid Disorder |
9.1% |
|
| Cerebrovascular Accident |
50.0% |
| Dyspnoea |
50.0% |
|
